首頁 > Nanjing Xinbell Pharmaceutical Technology Co., Ltd. > > 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-
1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-
  • 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-

1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-

產品價格 產品參數

參考價格: ¥ 2

最小起訂量:1

配送時間: 7

產品分類
企業圖片

    此公司沒有發布企業圖片!

相關產品
產品信息

Picture Destcription

Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib citrate is marketed as Xeljanz and Jakvinus.


Classification: PharmaceuticalCas NO.: 540737-29-9Molecular Formula: C16H20N6O.C6H8O7


參考價格: ¥ 2

最小起訂量:1

相關產品
瀏覽歷史
重庆时时彩开奖中心